These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24038425)

  • 41. The cost of monitoring warfarin in patients with chronic atrial fibrillation in primary care in Sweden.
    Björholt I; Andersson S; Nilsson GH; Krakau I
    BMC Fam Pract; 2007 Feb; 8():6. PubMed ID: 17324260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The cost-effectiveness of different management strategies for patients on chronic warfarin therapy.
    Lafata JE; Martin SA; Kaatz S; Ward RE
    J Gen Intern Med; 2000 Jan; 15(1):31-7. PubMed ID: 10632831
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transportation cost of anticoagulation clinic visits in an urban setting.
    Hwang JM; Clemente J; Sharma KP; Taylor TN; Garwood CL
    J Manag Care Pharm; 2011 Oct; 17(8):635-40. PubMed ID: 21942304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes of oral anticoagulant therapy managed by telephone vs in-office visits in an anticoagulation clinic setting.
    Wittkowsky AK; Nutescu EA; Blackburn J; Mullins J; Hardman J; Mitchell J; Vats V
    Chest; 2006 Nov; 130(5):1385-9. PubMed ID: 17099014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The patients' perspective of international normalized ratio self-testing, remote communication of test results and confidence to move to self-management.
    Grogan A; Coughlan M; Prizeman G; O'Connell N; O'Mahony N; Quinn K; McKee G
    J Clin Nurs; 2017 Dec; 26(23-24):4379-4389. PubMed ID: 28231618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes.
    Bloomfield HE; Krause A; Greer N; Taylor BC; MacDonald R; Rutks I; Reddy P; Wilt TJ
    Ann Intern Med; 2011 Apr; 154(7):472-82. PubMed ID: 21464349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation.
    Khan TI; Kamali F; Kesteven P; Avery P; Wynne H
    Br J Haematol; 2004 Aug; 126(4):557-64. PubMed ID: 15287950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The changing face of anticoagulation management: an improving countenance.
    Baker WL
    Pharmacotherapy; 2013 Nov; 33(11):1133-5. PubMed ID: 24590595
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.
    Ripley TL; Harrison D; Germany RE; Adamson PB
    Clin Ther; 2010 Mar; 32(3):506-14. PubMed ID: 20399987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trial.
    Woods K; Douketis JD; Schnurr T; Kinnon K; Powers P; Crowther MA
    Thromb Res; 2004; 114(3):161-5. PubMed ID: 15342212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of Chinese patients on warfarin therapy in two models of anticoagulation service - a prospective randomized trial.
    Chan FW; Wong RS; Lau WH; Chan TY; Cheng G; You JH
    Br J Clin Pharmacol; 2006 Nov; 62(5):601-9. PubMed ID: 17061966
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patient time requirements for anticoagulation therapy with warfarin.
    Jonas DE; Bryant Shilliday B; Laundon WR; Pignone M
    Med Decis Making; 2010; 30(2):206-16. PubMed ID: 19773584
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anticoagulation-related outcomes in patients receiving warfarin after starting levofloxacin or gatifloxacin.
    Mathews S; Cole J; Ryono RA
    Pharmacotherapy; 2006 Oct; 26(10):1446-52. PubMed ID: 16999655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Home monitoring of warfarin effects.
    Lippi G; Franchini M
    N Engl J Med; 2011 Jan; 364(4):378; author reply 378-9. PubMed ID: 21268733
    [No Abstract]   [Full Text] [Related]  

  • 55. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
    Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complications of warfarin therapy: causes, costs, and the role of the anticoagulation clinic.
    Hamby L; Weeks WB; Malikowski C
    Eff Clin Pract; 2000; 3(4):179-84. PubMed ID: 11183433
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial.
    Wilson SJ; Wells PS; Kovacs MJ; Lewis GM; Martin J; Burton E; Anderson DR
    CMAJ; 2003 Aug; 169(4):293-8. PubMed ID: 12925422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quality of life assessment in children commencing home INR self-testing.
    Jones S; Monagle P; Manias E; Bruce AA; Newall F
    Thromb Res; 2013 Jul; 132(1):37-43. PubMed ID: 23726963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Home prothrombin time monitoring: a literature analysis.
    Yang DT; Robetorye RS; Rodgers GM
    Am J Hematol; 2004 Oct; 77(2):177-86. PubMed ID: 15389909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.